Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/1/2025

Management of Third Stage of Labour

Core Components of Third Stage Management

  • The World Health Organization strongly recommends active management of the third stage of labour, which includes administration of a prophylactic uterotonic agent, delayed cord clamping for approximately 60 seconds, and controlled cord traction to deliver the placenta 1

Placental Delivery Timing

  • Spontaneous placental delivery should occur within 30 minutes of fetal expulsion, as retained placenta beyond 30 minutes increases postpartum haemorrhage risk 2
  • Manual removal of placenta should not be performed routinely except in cases of severe, uncontrollable postpartum haemorrhage 2, 1

Tranexamic Acid for PPH Prevention

  • The World Health Organization strongly recommends early administration of tranexamic acid 1 g IV over 10 minutes within 3 hours of birth for women with clinically diagnosed postpartum haemorrhage, in addition to standard uterotonic therapy 1, 3
  • Tranexamic acid must be given within 3 hours of birth, as effectiveness decreases by approximately 10% for every 15 minutes of delay 1, 3, 4
  • Tranexamic acid should not be given beyond 3 hours postpartum as it may be harmful 1, 3, 4
  • A second 1 g dose of tranexamic acid can be given if bleeding continues after 30 minutes or restarts within 24 hours 1, 3

Indications for TXA

  • Tranexamic acid should be administered in all cases of postpartum haemorrhage regardless of etiology, as it reduces bleeding-related mortality when given within 3 hours 1, 3
  • The number needed to treat is 276 to prevent one bleeding-related death 2

Common Pitfalls to Avoid

  • Manual removal of placenta should not be performed routinely before 30 minutes have elapsed, as this increases infection and haemorrhage risk 2, 1
  • Methylergonovine should not be used in hypertensive patients due to risk of severe vasoconstriction and hypertensive crisis 1, 3, 4
  • Tranexamic acid should not be administered beyond 3 hours postpartum as evidence suggests potential harm rather than benefit 1, 3, 4

Setting-Specific Considerations

  • Ensure availability of uterotonic agents and trained personnel in all birth settings 1
  • Rectal misoprostol 800-1000 μg can be used for treatment of active haemorrhage unresponsive to oxytocin in low-resource settings 4

REFERENCES

1

Management of Postpartum Hemorrhage [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

3

Management of Postpartum Hemorrhage [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

4

Management of Postpartum Hemorrhage [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025